Advertisement
U.S. markets open in 42 minutes
S&P Futures
6,019.75 +32.75 (+0.55%) Dow Futures
44,732.00 +337.00 (+0.76%) Nasdaq Futures
20,964.25 +114.50 (+0.55%) Russell 2000 Futures
2,442.00 +28.40 (+1.18%) Crude Oil
70.87 -0.37 (-0.52%) Gold
2,682.50 -29.70 (-1.10%)
SAB Biotherapeutics, Inc. (SABSW)
NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Follow
At close: 04:00PM EST
| Previous Close | 0.0669 |
| Open | 0.0508 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.0508 - 0.0730 |
| 52 Week Range | 0.0508 - 0.0730 |
| Volume | |
| Avg. Volume | N/A |
| Market Cap | N/A |
| Beta (5Y Monthly) | 0.64 |
| PE Ratio (TTM) | 0.25 |
| EPS (TTM) | 0.2920 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
TipRanksThese 2 “Strong Buy” Penny Stocks Are Set to Triple (or more), Say Analysts
The year is winding down, but the bull markets are still charging ahead, getting a boost from improved sentiment after the presidential election. While the next few months will be a time of transition, a few things are likely. The Trump administration is expected to pursue a far looser regulatory policy than the outgoing Biden government. Plans for individual tax cuts are projected to drive consumer spending, while reductions in corporate taxes could deliver an immediate boost to earnings. While
Simply Wall St.SAB Biotherapeutics Third Quarter 2024 Earnings: US$1.12 loss per share (vs US$0.97 loss in 3Q 2023)
SAB Biotherapeutics ( NASDAQ:SABS ) Third Quarter 2024 Results Key Financial Results Net loss: US$10.3m (loss widened...
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.